ErinALarkinsMD

Oncology • Bethesda, MD

Assistant Professor, Medicine, Uniformed Services Hebert SOM

Join to view full profile

Are you Dr. Larkins?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 38 invites waiting!
Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

Office
8901 Wisconsin Ave
Wrnmmc, Dept Of Hem-Onc, America Bldg, 3rd Floor
Bethesda, MD 20889
Phone+1 301-319-2131

Summary

Dr. Erin Larkins, MD is an oncologist in Bethesda, Maryland. She is currently licensed to practice medicine in Virginia. She is affiliated with Walter Reed National Military Medical Center and is an Assistant Professor at Uniformed Services Hebert SOM.

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2003 - 2006
UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 2000

Certifications & Licensure

VA State Medical License 2001 - 2026
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

78 citations
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer
Luckson Mathieu, Sujay Shah, Lee Pai-Scherf, Erin Larkins, Jonathon Vallejo
The Oncologist. 2021-05-01
47 citations
FDA Benefit‐Risk Assessment of Osimertinib for the Treatment of Metastatic Non‐Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
Lauretta Odogwu, Luckson Mathieu, Kirsten B. Goldberg, Gideon M. Blumenthal, Erin Larkins
The Oncologist. 2018-03-01
30 citations
FDA Approval Summary: Nivolumab in Combination with Ipilimumab for the Treatment of Unresectable Malignant Pleural Mesothelioma.
Erica C Nakajima, Paz J. Vellanki, Erin Larkins, Somak Chatterjee, Pallavi S. Mishra-Kalyani
Clinical Cancer Research. 2021-08-30

Press Mentions

Dr. David Gerber, University of Texas Southwestern, and LUNGevity Foundation Publish Recommendations to Simplify and Harmonize Lung Cancer Clinical TrialsAugust 30th, 2022
Will FDA Mandate More Rigorous Design for Trials of Perioperative Therapies?August 8th, 2024